We first combined our RNA biomarkers including NAMPT and the coatomer protein complex subunit zeta 1 (COPZ1), a blood RNA biomarker replicated previously in the same subset of samples from Parkinson’s Progression Markers Initiative (PPMI)15. Here, NAMPT is linked to Parkinson disease.